Compare

ARK Genomic Revolution/£ARCG

1D1W1M3M6MYTD1Y5YMAX

About ARCG ETF

This product is actively managed and invests primarily in global equity securities of companies involved in the genomic revolution. These are companies that are substantially focused on or benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, improvements and advancements in genomics into their business, such as by offering new products or services that rely on genomic sequencing, analysis, synthesis or instrumentation. These companies may include ones across multiple sectors, such as healthcare, information technology, materials, energy and consumer discretionary.
Ticker
£ARCG
Fund name
ARK Genomic Revolution
Primary listing
LSE
Fund Manager
ARK Invest
Share currency
GBP
USD
7
Documents
Costs disclosure document

ARCG Metrics

£91M
-

ARCG Fund Highlights

This product is actively managed and invests primarily in global equity securities of companies involved in the genomic revolution.
Accumulating
0.75%
0.80%
0.03%

ARCG Fund Breakdown

Top holdingsSectorsCountries
Tempus AI

9.42%

Twist Bioscience

7.56%

10x Genomics

6.43%

CRISPR

5.23%

Natera

4.96%

Eli Lilly

4.96%

CareDx

4.93%

Absci

4.83%

Illumina

4.61%

Other

47.07%

Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.